PortfoliosLab logo

China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)

Equity · Currency in HKD · Last updated May 31, 2023

Company Info

ISINBMG210A71016
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market CapHK$17.82B
EPSHK$0.58
PE Ratio8.51
PEG RatioN/A
Revenue (TTM)HK$9.56B
Gross Profit (TTM)HK$5.25B
EBITDA (TTM)HK$3.33B
Year RangeHK$3.28 - HK$5.40
Target PriceHK$1.80

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of HK$10,000 in China Grand Pharmaceutical and Healthcare Holdings Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%2023FebruaryMarchAprilMay
26.13%
2.09%
0512.HK (China Grand Pharmaceutical and Healthcare Holdings Ltd)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 0512.HK

Return

China Grand Pharmaceutical and Healthcare Holdings Ltd had a return of 9.13% year-to-date (YTD) and 19.97% in the last 12 months. Over the past 10 years, China Grand Pharmaceutical and Healthcare Holdings Ltd had an annualized return of 25.70%, outperforming the S&P 500 benchmark which had an annualized return of 10.20%.


PeriodReturnBenchmark
1 month-1.57%-0.57%
Year-To-Date9.13%7.49%
6 months22.14%1.61%
1 year19.97%-3.55%
5 years (annualized)-2.57%8.34%
10 years (annualized)25.70%10.20%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20236.09%-8.61%1.12%13.08%
202222.32%11.92%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
0512.HK
China Grand Pharmaceutical and Healthcare Holdings Ltd
0.35
^GSPC
S&P 500
0.17

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current China Grand Pharmaceutical and Healthcare Holdings Ltd Sharpe ratio is 0.35. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.502023FebruaryMarchAprilMay
0.35
0.10
0512.HK (China Grand Pharmaceutical and Healthcare Holdings Ltd)
Benchmark (^GSPC)

Dividend History

China Grand Pharmaceutical and Healthcare Holdings Ltd granted a 2.19% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.11 per share.


PeriodTTM2022202120202019
DividendHK$0.11HK$0.11HK$0.11HK$0.10HK$0.09

Dividend yield

2.19%2.39%1.75%1.45%2.15%

Monthly Dividends

The table displays the monthly dividend distributions for China Grand Pharmaceutical and Healthcare Holdings Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2023HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.11HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.11HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.10HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2019HK$0.09HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%2023FebruaryMarchAprilMay
-61.12%
-12.20%
0512.HK (China Grand Pharmaceutical and Healthcare Holdings Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the China Grand Pharmaceutical and Healthcare Holdings Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the China Grand Pharmaceutical and Healthcare Holdings Ltd is 99.52%, recorded on Sep 5, 2006. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.52%Mar 6, 19961905Sep 5, 2006
-11.64%Jan 26, 199610Feb 8, 199614Mar 4, 199624
-2.32%Jan 11, 19962Jan 12, 19962Jan 16, 19964
-0.66%Jan 19, 19961Jan 19, 19961Jan 22, 19962

Volatility Chart

The current China Grand Pharmaceutical and Healthcare Holdings Ltd volatility is 9.74%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%2023FebruaryMarchAprilMay
9.74%
3.55%
0512.HK (China Grand Pharmaceutical and Healthcare Holdings Ltd)
Benchmark (^GSPC)